Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction | Zendy

Elliott M. Antman | Zendy; David A. Morrow | Zendy; Carolyn H. McCabe | Zendy; Sabina A. Murphy | Zendy; Mikhail Ruda | Zendy; Zygmunt Sadowski | Zendy; Andrzej Budaj | Zendy; José LópezSendón | Zendy; Sema Güneri | Zendy; Frank Jiang | Zendy; Harvey D. White | Zendy; Keith A.A. Fox | Zendy; Eugene Braunwald | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction

Author(s) -

Elliott M. Antman,

David A. Morrow,

Carolyn H. McCabe,

Sabina A. Murphy,

Mikhail Ruda,

Zygmunt Sadowski,

Andrzej Budaj,

José LópezSendón,

Sema Güneri,

Frank Jiang,

Harvey D. White,

Keith A.A. Fox,

Eugene Braunwald

Publication year - 2006

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa060898

Subject(s) - medicine , fibrinolysis , heparin , myocardial infarction , cardiology , low molecular weight heparin , st elevation

Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients with ST-elevation myocardial infarction. We compared a low-molecular-weight heparin, enoxaparin, with unfractionated heparin for this purpose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore